Analyst consensus rating
CAMP4 Therapeutics Analyst Rating: Strong Buy
Direct answer
CAMP4 Therapeutics's consensus rating is Strong Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.22.
Forecast evidence checked November 14, 2026.
Get free CAMP4 Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.80
- Average price target
- $10.22
- High price target
- $15.00
- Low price target
- $6.00
- Low target gap
- +57.9%
- Target upside
- +169%
- High target gap
- +294.7%
- Target range width
- 236.8%
- Consensus rating
- Strong Buy
- Analysts
- 9
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for CAMP4 Therapeutics?
CAMP4 Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $10.22.
How far are CAMP4 Therapeutics's low and high targets from the recorded price?
The low target implies +57.9%, while the high target implies +294.7%.
How many analysts are included in CAMP4 Therapeutics's consensus?
The verified consensus includes 9 analysts.
How is CAMP4 Therapeutics's target upside or downside calculated?
The average target of $10.22 is divided by the recorded price of $3.80, then one is subtracted to produce +169%. This does not guarantee a future return.
When was CAMP4 Therapeutics's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.